/
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Locally Advanced is a moderately active landscape with 35 programs across 34 companies. The most active players are Sichuan Baili Pharmaceutical Co., Ltd., ImmuneOncia Therapeutics Inc., Anbogen Therapeutics, Inc.. 11 programs are in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Bubble size = clinical trials
Key Players
Pipeline
Analysis
76%
Small molecule
25 of 33 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 33 classified programs, each share of the total. Modality classified for 100% of 35 pipeline programs.
Analysis
146
clinical trials
Clinical Trials
146 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)